semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Breast Cancer Chemotherapy Febrile Neutropenia Breast cancer patients ≥18 years Indication for 3-weekly chemotherapy Considered fit enough to receive chemotherapy, with adequate renal and hepatic function Planned a chemotherapy regime in adjuvant, neo-adjuvant, advanced setting with an increased risk of febrile neutropenia, i.e Regimes with >20% risk of febrile neutropenia e.g. TAC (docetaxel, adriamycin, cyclophosphamide) AT (adriamycin, docetaxel) Regimes with 10-20% risk of febrile neutropenia (e.g. AC, doxorubicin and vinorelbine, or docetaxel monotherapy) in the presence of ≥1 patient risk factor (>65 yrs, extensive bone marrow involvement or prior extensive radiotherapy on bone tissue Prior chemotherapy ECOG performance status of 2 or more, grade 2 or higher liver function abnormalities)  Active uncontrolled infection Inadequate renal or hepatic function Any evidence or history of hypersensitivity or other contraindications to G-CSF medication Not recovered from acute toxicities of prior therapies Absolute neutrophil count (ANC) <1.5 x 109/l, not caused by bone marrow involvement
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 6.0-999.0,  Cystic Fibrosis Diagnosis of Cystic Fibrosis Two positive cultures for Burkholderia dolosa lung infection  Positive pregnancy test or currently breast feeding (if applicable) Known sensitivity to Amiloride
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 40.0-999.0,  Osteoarthritis of the Knee Symptomatic idiopathic osteoarthritis of the knee for a minimum of six months duration requiring treatment with either an analgesic or anti-inflammatory agent on a regular basis (greater than or equal to three days/week) for at least three months A history of osteoarthritis of the knee characterized by pain of at least a moderate intensity Demonstrated radiographic evidence of mild to moderate osteoarthritis based on the Kellgren and Lawrence radiographic entry of grade 2 or 3 osteoarthritis Subjects' physical ability was to be either American College of Rheumatology (ACR) Function Class I or II At the baseline visit, subjects must have reported a maximum pain intensity experienced over the previous 24 hours of at least moderate on a five-point scale of none(0), mild(1), moderate(2), moderately severe(3), or severe(4) in order to be enrolled in the study  Medical history, physical examinations, or radiographs suggestive of other types of arthritis, pseudogout, collagen vascular disease or fibromyalgia Medical or psychiatric conditions that may influence absorption, metabolism, or excretion of the study medications or interfere with interpretation of adverse reactions to the study drug History of allergy, sensitivity, contraindication or non-response to acetaminophen, rofecoxib, or drugs classified as NSAIDs including aspirin Use of concomitant medications that might interfere with study drug assessments, including intra-articular corticosteroids Signs of active knee inflammation, morning stiffness of greater than 30 minutes duration Rheumatoid factor quantitative value greater than or equal to 40 IU/mL or a Westergren erythrocyte sedimentation rate greater than or equal to 40 mm/hour ACR functional class III or IV, or unable to walk without assistive devices Pregnancy, lactation, or expect to become pregnant within one month of study completion
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-85.0,  Aspiration Pneumonia Aspiration pneumonia after neurological insults (e.g. stroke) Ability to understand the purpose of the research Appropriate hand motor control Inability to improve under standard treatments (speech-language pathologists) Acceptance of a tracheostomy  Lack of understanding the research Poor hand motor coordination Uncontrolled seizures Pregnancy Refusal to accept a tracheostomy
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Antibiotic-Associated Diarrhea Clostridium Difficile Patients with diarrheal stools considered to be antibiotic associated  Inability of sign consent Patient with other known gastrointestinal disease Patients receiving tube feeding or fecal incontinence prior to receiving antibiotics
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Stroke, Acute Subject For in the study, subjects must fulfill all of the following Written Informed Consent Eighteen years of age or older Symptoms consistent with acute stroke (ischemic or hemorrhagic) Acute presentation of stroke symptoms, per bedside physician discretion (onset generally less than 12 hours and likely less than 3 hours) Subject  The following is the sole criterion for from the study Unlikely to complete study through 90-day follow-up
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 0.0-18.0,  Viral Pneumonia Bacterial Pneumonia Children from birth to 18 years intubated for respiratory failure or for surgery as mentioned above within 48 hours of intubation  Use of antibiotics >72 hours preceding the study (not applicable to the definite bacterial pneumonia group) Use of oral/parenteral glucocorticoid therapy <2 weeks prior to admission Presence of tracheostomy Active treatment for pulmonary arterial hypertension Mechanical ventilation with FIO2 >0.6, MAP>20 Presence of severe pulmonary interstitial emphysema, pneumothorax, bradycardia (heart rate, <80 beats/min in neonates, <70 beats/min in infants), hypotension (mean arterial pressure, <40 mm Hg in neonates, <50 mm Hg in infants), and platelet count of <30,000/mm3 Immunodeficient or immunocompromised due to other conditions Enrollment in another interventional study that employs BAL
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Antibiotic-Associated Diarrhea admitted patients who developed diarrhea in 72 hours since the beginning of admission patients age above 18 years patients received antibiotics during admission  other reasons of diarrhea drugs induced diarrhea length of time since the beginning of diarrhea is shorter than 72 hours patients had diarrhea during the first day of admission
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Constipation Adult, 18 years old or greater. 2. The patient is able to provide informed consent. 3. Anticipated duration of hospitalization of at least 7 days. 4. Woman of childbearing potential must have a negative serum pregnancy test at enrollment. Exclusions for testing two years or greater postmenopausal, hysterectomy or tubal ligation. 5. Use of opioid for post-op analgesia following orthopedic surgical procedures as defined as IV, IM, transdermal or PO opioid received within the prior 24 hours of hospitalization for pain control, and expectation that an opioid will be continued for pain control Medication may be administered on a PRN (as needed) basis or scheduled basis One or greater doses has been received within the 24 hours prior to enrollment as determined by medication administration recorded from the acute care facility or RIC MAR. 6. At least one associated symptom of constipation at the time of admission, such as, but not limited to Lumpy or Hard stools Feeling of incomplete evacuation of bowels Abdominal cramping or pain Straining with movement of bowels or painful bowel movement effort Need for manual assistance to have a bowel movement  Known allergy or sensitivity to the study medications 2. Females who are pregnant 3. Diarrhea on the day of admission 4. Diagnosis of Clostridium difficile infection during the current hospitalization 5. Pre-existing medical condition or surgical procedure, which is known to commonly lead to bowel dysfunction such as, but not limited to Crohn's disease Ulcerative colitis Multiple sclerosis Cerebral palsy Spinal Cord Injury Colectomy Malabsorption Syndrome Irritable Bowel Syndrome Abdominopelvic neoplasm (gastric, colon cancer)
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Staphylococcal Infections Patients need to be administered Linezolid in order to be enrolled in the surveillance  Patients not administered Linezolid
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Pain Inflammation The subject has signed a written informed consent to participate in the study and has agreed to follow instructions and complete all required questionnaires Females, 18 years of age or older She has to undergo a planned laparoscopy for mentioned indications with a duration that exceeds 60 minutes  Pregnancy Immunodeficiency Refuse or unable to sign informed consent Chronic diseases (i.e. COPD, Crohn, cardiac…) Mental diseases
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 0.417-2.0,  Diarrhea, Infantile Children between the ages of 5 months and 2 years of age admitted in the inpatient pediatric ward of Bhatpara Sub divisional Hospital. 2. Infants with more than 3 stools/day which is more frequent than the usual bowel habit of the study subject 3. The consistency of the stool is such that it takes the shape of the container into which it is put in. 4. Duration of symptoms should be less than 14 days. -  Children with bloody diarrhea 2. Children with lethargy, fever or other signs of septicemia 3. Children with shock. 4. Children unable to take medications orally. 5. Children with impaired consciousness. 6. Children whose parents refuse permission to be included in the study. 7. Children who are not usual residents of the area and will not be available for follow up. 8. Children with chronic illnesses such as congenital heart disease, renal failure, chronic liver disease, chronic lung disease, inflammatory bowel disease, immune deficiency etc. -
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Clostridium Difficile-Associated Diarrhea Age 18 or older Written informed consent At least 3 unformed or watery stools in each of the 2 previous 24 hour periods Confirmed diagnosis of C. difficile associated diarrhea  Pregnant or breast feeding women Known allergy to milk or milk products Other etiology of diarrhea Active or Chronic conditions: IBD, short bowel syndrome, ischemic colitis Ileus Pseudomembranous colitis White blood count > 50,000 Blood in stools Laxatives or motility drugs within 12 hours Inability to participate in adequate follow up Clinically unstable
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-55.0,  Clostridium Difficile Infection Clostridium Difficile Diarrhea Adult males or females, 18 years in good general health  Evidence of current C. difficile infection, as determined by a positive stool C. difficile cytotoxin assay at screening Evidence of any previous antibiotic-associated diarrhea caused by any etiology including C. difficile that required medical intervention or medication Active or inactive irritable bowel disease, chronic abdominal pain, chronic diarrhea of any etiology, or inflammatory bowel disease
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Acute Lung Injury Acute Respiratory Distress Syndrome Adult male or female patients with ALI/ARDS confirmed by the combination of the following diagnostic An initiating clinical condition (e.g. sepsis, pneumonia, aspiration pneumonia, pancreatitis etc.) Acute onset Bilateral infiltrates documented by chest radiograph at end-aspiratory position The absence of clinical evidence of left atrial hypertension ALI: partial pressure of oxygen (PaO2) / fraction of inspired oxygen (FiO2) ratio ≤300 mmHg in a stable state after the patient has adapted to standardised ventilation. (Within the UK this equates to <40kPa) ARDS: PaO2 /FiO2 ≤200 mmHg in a stable state after the patient has adapted to standardised ventilation. (Within the UK this equates to <26.7kPa) Provision of signed written informed consent from the patient or patients legally authorized representative Age greater than or equal to 18 Initiation of study drug within 48 hours of the diagnosis of ALI/ARDS  Patients with burns Women known to be pregnant, lactating or having a positive or indeterminate pregnancy test Patients with significant Chronic Obstructive Pulmonary Disease requiring ongoing treatment e.g. chronic use of oxygen or ventilatory support at home prior to admission Patients with primary lung cancer or the presence of secondary metastases in the lungs Patients requiring treatment for congestive heart failure Patients receiving renal dialysis therapy for chronic renal failure Patients taking immunomodulatory therapy or oral steroids on admission Prior use of interferon Inability to maintain blood pressure to ensure adequate end organ perfusion. It should be noted that the use of plasma colloids or vasopressor agents is allowed to achieve the maintenance of blood pressure Current participation in another experimental treatment protocol
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Diarrhea Constipation Patients who were hospitalized in the Department of Geriatric Orthopedic Rehabilitation a week before their enrollment in the study and signed an informed consent  Known or suspected allergy to any probiotics Neutropenia Inability to sign an informed consent